Added to YB: 2023-11-20
Pitch date: 2023-11-20
PROK:US [bullish]
ProKidney Corp.
+21.67%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
Market Cap
$280.3M
Pitch Price
$1.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
-8.21
P/E
-3.64
EV/Sales
1.8K
Sector
Biotechnology
Category
N/A
Show full summary:
ProKidney Corp. Class A PROK:US
A summary for this pitch has not been created yet.
Read full article (0 min)